Member Info for JustHereForHemo

Posti, that is pretty rich for anyone who is sitting on a public BB ranting to complain that someone else re-tweets on twitter....
Ok however though, even though I should not, I will engage.....
What exactly do you think Vlad should be doing? Because to me it looks like the extension was not for Vlad to be sitting at a workbench with his Bunsen burner and tweeters. Why? Because it looks very much like most of the "Science" is done.
The mice have proven their worth, they clearly work and are being used by other partners, they are part and parcel of the Orgenesis BioDefence platform so they are already a commercial product, so while there may be improvements we dont need Vlad actively working on the mice.
Ok what about CDX for Leukaemia? They are ready for the next stage which involves human patients, that means recruiting screening selecting patients with AML, that will be done by others not Vlad, will be be changing or modifying the anti-body now its pretty much done with the pre-clinical stages??????? ABSOLUTELY NOT if its passed the initial stages its locked down unless there is a very good reason to make changes.
IND-enabling studies for HEMO-CAR-T? Will he be making changes? NO
Basically all the work now is either waiting for results, filing results, looking for patients, setting up studies, applying for orphan status, applying for IND, applying for patents....
If you want to tell someone to do their jobs speak to the FDA and tell them to hurry up, speak to hospitals and tell them to start trials again.
I would assume Vlad has got masses and masses of studies and results that prove the work Hemo have been working on these past few years and would love nothing more than to share with the scientific community but he is waiting for final sign off and approval from the FDA. So if he has some spare time and he decides to read a scientific publication or an interesting article on Covid-19 and he decides to like or re-tweet it, get down of your god damn high horse and redirect your frustration somewhere else.

Seriously? Do people not realise how much information is already publicly available? The amount of info out there on Hemo is staggering if you take 30 mins to look. People may laugh when they see time and again people like myself, the doc, a few others posting that they are up to xMil shares with ZERO intention of selling.
There is a very good reason, the SP right now is pure and utter BS.
I will agree its totally frustrating the SP and as an investor I would love it to be higher, but hey ho its not, but if you forget Hemo for a second and take a look around at the rest of the market and its like unless you are literally able to print gold your SP is getting destroyed. Hemo has a big part to play in Orgenesis who very recently released a BioDefence platform which will pretty soon likely used by the US and Israeli DoD, they will be printing money, but look at their SP on the close yesterday, its wayy outside the charts in a massive sell off ON GOOD NEWS.
You can blame Vlad all you want but he has pretty much kept to the plan and kept to his word.
Read the opening statement when Hemo was listed on the LSE, granted the timetable HAS slipped a little, but understandable, the key milestones are either hit or still clearly in focus and very close.
Watch his interviews where he talks about the mice and key partners. Its clear that has been honoured but as quite clearly shouted from the hills. Hemogenyx is contractually restricted from talking or naming the pharma customers for these mice right now.

Whatever price you have paid for your shares is a bargain, they have never went above 14/15p. It is my honest believe that in the short term that will be dwarfed. The progress in the multiple ares of work are beginning to come to a head with results on almost all projects due in the next few months.

When the research and development dries up and we move to having projects that are revenue generating streams one of 2 things will happen:
1, takeover from a big global pharma - You will be paid handsomely for your shares, a premium over whatever the market price is, you do not need to do anything the shares will be taken from you. You may also get shares in the parent company, depends on teh terms.
2, No takeover and Hemo starts to make significant money from licencing/mice. You will be paid handsomely in the form of dividends, you do not need to do anything, dividends will be paid into your dealing account. After this has happened and becomes predictable the SP will be based on dividends and company assets, you will be able to trade at will and it really will have little impact on the SP. Shorters etc will not be able to F with the SP like they can now.

From what I understand of the matter it was not targeted as an investor oriented tweet but more of a public health and responsibility message.
If you followed Hemogenyx you would know they have been testing their own staff from the beginning, in house. That does not mean they are in anyway developing or intend to start selling a test. There are companies doing that and thats their SINGLE product line. For Hemo it was a necessity to keep safe and continue working.
Hemogenyx have not shut up shop during covid, they have not furloughed their staff, they have not decided to wait for it all to blow over. They have been using PPE, keeping safe and testing their staff so they can continue working.

I Believe there was news recently that other companies had to shut down because the number of staff who had got infected and spread the virus within the workspace. This virus is the bread and butter of Hemogenyx. If Hemo are able to keep working then there is no reason why their approach cannot be replicated across other workspaces so that if there is a second wave the economy does not have to stop again.

People really need to stop before they come on to public boards shouting their ill informed opinions everywhere.

Very jealous, but very nice holding :-)

Regardless of our involvement or lack of, expect nothing until they absolutely have too. If its not leaked and proven like the orgenesis BioPlatform then expect radio silence for at least 4-5 weeks

I agree chances of hemo being involved in the human trials are slim at best. If anything mist likely will be use of the mice in pre clinic stages

Trilla, re the in-house test, dont read too much into it, hemo have been inhouse testing employees since day dot. They were talking about it before most people knew what covid19 was.
Its not a waste of money because it allows them to keep working and not social distance in thr office. Also they are a bio company they already had the equipment. I cant see them packaging and selling an actual test but they are or were working on an advanced vulnerability test to see who is at risk.

Tempted to say something about unfounded accusations or something lol ;-) But I won't, i think tomorrow will be fantastic.
It really does look like hemo mice have been used to shortcut the approvals process, the timelines are just too short, must be our humanised mice are that good they can prove the safety without human volunteers?

Smile, tomorrow is another day :-)
Have faith people, it will come good, we didnt do too bad all things considered.

Im still a few k in profit here with hemo. Dont get me wrong its getting very close but its still blue believe it or not lol. I have a year to pay off the loan, zero interest and no repayments along the way so worst comes to worst I could pay it off tomorrow and still be up.

ok, well dont worry, if a big seller was trying to offload they would not go down that small they would still be selling in blocks of 100-200k. And the really big sellers will just get a MM to handle it for them anyway and sell it all like the 5m sell a few days ago. really dont see 5k sells having any impact

There are actually 3 with them, one is pre-clinical. Its also possible that Lilly or others are using our mice as the platform to test and produce these antibodies... What caught my attention was how they have almost skipped to the front of the line, and when you see that you have to wonder what has enabled them to do that?

Condensed version of below:
April - Hemo state they are doing Proof of Concept with BioDefence using mice will identify Covid-19 antibody
May - Orgenesis go public with plans to develop BioDefence platform using our mice with 12% royalties previously agreed
June - Lots of candiates are going to trials with Covid-19 antibodies, some alot faster than others: https://theprint.in/health/us-drug-company-eli-lilly-says-its-covid-treatment-could-be-ready-as-early-as-september/439468/

The aim of Hemogenyx was to DEMONSTRATE how the mice can be used to quickly identify antibodies not to develop and actual platform the likes of Orgenesis has done. Its probably safe to assume whats mentioned in that RNS which was almost 2 months ago in April, then it was May when Orgenesis announced they were working on the BioShield platform.
It also states in the Hemogenyx RNS:
"With the outbreak of COVID-19, the Company concluded that it would potentially be applicable to the SARS-CoV-2 virus. As part of its studies, Hemogenyx will transplant cells from blood samples from patients who are either recovering or have already recovered from COVID-19 into its ApbHC humanized mice. The process will allow the Company's scientists to recreate a set of anti-SARS-CoV-2 virus antibodies which could be used for the treatment of COVID-19."

Now given that Orgenesis are going ahead with the Platform using OUR mice its clear we successfully demonstrated that the mice work. The release the platform and Hemo get 12% job done.

We also very likely and some time ago able to: "recreate a set of anti-SARS-CoV-2 virus antibodies" as this was probably the proving point for the platform in the first place which likely secured the deal and maybe with better terms than 12%, who knows. Point is if we did manage to recreate antibodies then I am sure there is a secret deal going on somewhere and these antibodies are in trials as we speak. I am not saying they are involved here but just google and there are a few candidates, I share this one based on the speed with which they have progressed which advanced humanised mice would enable:
https://theprint.in/health/us-drug-company-eli-lilly-says-its-covid-treatment-could-be-ready-as-early-as-september/439468/

Sentiment is already coming here, the SP did rise yesterday based on news from Orgs, not alot but it broke the downward spiral. Finally people are starting to see that there is an actual revenue stream beginning to appear and Hemo is going to be a substantial player in the field. They have done alot of work and its only recently started to show. As more and more connections are proven to other companies the market will react positively.

You made the price tick up a little so its showing as a sell :P

Proof in point, question was asked what can we expect this to go to on RNS, we have Letitroll say 7p+ and within minutes we have an order put on the books private seller to sell at 7p :P
So many short term investors just here to cream off a few percent and cannot see the wood for the trees, everyone so impatient, even though you dont have to do anything but wait here, how much money do you earn in 5 weeks working?

Quite frankly we never should have went below 8-9p before any news. Forgetting this deal which is big in its own we are on the cusp of stage 1 trials with Global Co for Leukaemia BMT treatments. Everything was on hold for Covid 19 but things are firing back up now. In terms of value? Share Price? its almost irrelevant. Whatever the share price is when we prove the treatments work, pass the early stages of trials and get Orphan Drug status, that share price is going to be paid with a hefty premium by some very rich and very powerful Global Pharma.
Other shares have the advantages of manufacturing and selling a physical item, like a test worth £10 and you can manufacture for £1 and make 100k is 900k profit. People can easily understand that and do simple maths and invest.
Hemo is manufacturing IP, they are creating something that others will licence or buy the rights to use in future.
The markup on pharma is HUGE and when people realise the potential here they are going to look back to when the sp was in single figures and slap themselves.

What we need is someone in the field to have a look at the Orgs Platform, tell us what the target market is, I am guessing governments and militaries around the world. Tell us what sort of budget is likely to be spent on the platform, IE will it be licenced as a JUST IN CASE line of defence to have ready or paid for as and when required?

In terms of saying what rise we could expect, I have my own opinion but if i say it in public then people will just go and set a limit sell at that and it will be a big drop when it hits. If people want to sell or slice thats their own decision but it shouldn't be a race to sell, people should see the bigger picture and hold.

Bythepool - Re second wave, I hope there is not a massive second wave but I feel it is unavoidable in SOME places like the US is perfect example, Trump is starting his live packed rallys next week and encouraging his core to not wear masks and break any lock down. Its just not possible that under those conditions without a vaccine to contain a second wave. The UK and the US are seeing mass protests, the one good thing is with the protests most are wearing masks, but they are very close together, the chances of containing the virus in those circumstances is tiny. That said, vaccine may be close, a few months hopefully! (Unlikely to be connected to Hemo but I dont care who brings it to market if it saves lives)

RE your other point about the information already being out there.
You are 100% correct
The information is there in black and white, and many investors are in for the long haul because we bothered to read it. However there are masses of traders, derampers and unicorn chasers who just want a quick fast easy buck and if it involves reading full stop its too much effort. They want an RNS that says:
Orgenesis partnered with Hemogenyx have today released the BioDefence Platform aimed at targeting Disease X.... Hemogenyx are to receive 12% of the revenue.
And it will have to come direct from Hemogenyx or they wont believe it either.
Ideally with a pink bow and a bell, with pictures.
People HATE doing any sort of work and research.

Saw that Groover. The second wave world wide is going to completely decimate the stats from wave 1.
With the numbers we can expect and the mass gatherings track and trace is going to be pointless.
We are going to move very quickly to a treat-vaccinate stage. Get the best treatments available and treat people who are sick, cure the disease and let it burn itself out, but we can only do that if we get the death rate way down. Then wait for the vaccine and eradicate it with vaccination and herd immunity. But in terms of containing it? too late.